Acrivon Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $1.27-$3.56 |
Market Cap | $79.2M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.88 |
News
See moreYahoo Finance • last month
Acrivon Therapeutics GAAP EPS of -$0.43 beats by $0.07
Yahoo Finance • 4 months ago
Acrivon Reports First Quarter 2026 Financial Results and Highlights Progress Towards Key 2026 Clinical Catalysts
Yahoo Finance • 9 months ago
3 Promising Penny Stocks With Market Caps Over $70M
Yahoo Finance • 10 months ago
Acrivon Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
About
CEO | Dr. Peter Blume-Jensen M.D., Ph.D. |
CFO | Dr. Adam D. Levy M.B.A., Ph.D. |
Address | 480 Arsenal Way, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 74 |